LOS ANGELES CAPITAL MANAGEMENT LLC - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q4 2022$317,042
-14.5%
6,351
-30.1%
0.00%0.0%
Q3 2022$371,000
-25.8%
9,0870.0%0.00%0.0%
Q2 2022$500,000
+51.5%
9,0870.0%0.00%
+100.0%
Q1 2022$330,0009,0870.00%
Other shareholders
LEGEND BIOTECH CORP shareholders Q3 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 814,586$54,715,74220.16%
HHLR ADVISORS, LTD. 6,436,533$432,341,9229.65%
Paradigm Biocapital Advisors LP 2,025,480$136,051,4929.23%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,123,828$75,487,5279.13%
RA Capital Management 6,264,707$420,800,3698.28%
Iron Triangle Partners LP 452,629$30,403,0904.44%
Nicholas Investment Partners, LP 593,010$39,832,4822.98%
Old Well Partners, LLC 45,200$3,036,0842.63%
Avidity Partners Management LP 967,000$64,953,3902.62%
E Fund Management (Hong Kong) Co., Ltd. 52,759$3,5442.23%
View complete list of LEGEND BIOTECH CORP shareholders